Byung Ha Lee

2.0k total citations
61 papers, 1.5k citations indexed

About

Byung Ha Lee is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Byung Ha Lee has authored 61 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Oncology, 24 papers in Molecular Biology and 21 papers in Immunology. Recurrent topics in Byung Ha Lee's work include CAR-T cell therapy research (15 papers), Plant Molecular Biology Research (14 papers) and Plant Reproductive Biology (10 papers). Byung Ha Lee is often cited by papers focused on CAR-T cell therapy research (15 papers), Plant Molecular Biology Research (14 papers) and Plant Reproductive Biology (10 papers). Byung Ha Lee collaborates with scholars based in United States, South Korea and Australia. Byung Ha Lee's co-authors include Jeong Hoe Kim, Cuong Q. Nguyen, Ammon B. Peck, Sangman Lee, John A. Chiorini, Jae‐Heung Ko, Jae‐Hong Pak, Yi Lee, Hongen Yin and Wendy C. Carcamo and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Byung Ha Lee

57 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Byung Ha Lee United States 22 639 559 396 347 302 61 1.5k
Qingguo Zhao China 21 774 1.2× 422 0.8× 85 0.2× 143 0.4× 130 0.4× 38 1.4k
Paola Moretto Italy 21 820 1.3× 96 0.2× 126 0.3× 57 0.2× 122 0.4× 39 1.5k
Haitao Gu China 17 708 1.1× 176 0.3× 98 0.2× 60 0.2× 86 0.3× 42 1.2k
Kana Hasegawa Japan 14 619 1.0× 566 1.0× 82 0.2× 121 0.3× 96 0.3× 36 1.2k
Feifei Sun China 19 513 0.8× 98 0.2× 75 0.2× 69 0.2× 195 0.6× 106 1.1k
Lan Yu United States 15 1.1k 1.7× 72 0.1× 1.9k 4.9× 180 0.5× 313 1.0× 16 2.3k
Gökhan Cildir Australia 9 683 1.1× 87 0.2× 282 0.7× 171 0.5× 93 0.3× 14 1.2k
Souichi Oomizu Japan 29 844 1.3× 83 0.1× 1.4k 3.6× 69 0.2× 348 1.2× 42 2.1k
Madalena Costa Portugal 18 482 0.8× 120 0.2× 113 0.3× 76 0.2× 63 0.2× 36 1.1k
Marco Averbeck Germany 18 337 0.5× 55 0.1× 253 0.6× 75 0.2× 117 0.4× 33 1.1k

Countries citing papers authored by Byung Ha Lee

Since Specialization
Citations

This map shows the geographic impact of Byung Ha Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Byung Ha Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Byung Ha Lee more than expected).

Fields of papers citing papers by Byung Ha Lee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Byung Ha Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Byung Ha Lee. The network helps show where Byung Ha Lee may publish in the future.

Co-authorship network of co-authors of Byung Ha Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Byung Ha Lee. A scholar is included among the top collaborators of Byung Ha Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Byung Ha Lee. Byung Ha Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramaswami, Ramya, Angela Shaulov Kask, Leonard D’Amico, et al.. (2025). Phase I study of efineptakin alfa (NT-I7) for the treatment of Kaposi sarcoma. Journal for ImmunoTherapy of Cancer. 13(2). e010291–e010291. 2 indexed citations
2.
Kim, Richard D., Hirva Mamdani, Minal Barve, et al.. (2024). A phase 2a study of NT-I7 (efineptakin alfa), a long-acting IL-7, and pembrolizumab to evaluate efficacy, including overall survival, in hard-to-treat gastrointestinal tumors.. Journal of Clinical Oncology. 42(16_suppl). 2621–2621. 1 indexed citations
3.
Li, Dan, T. Jake Liang, Laura Hutchins, et al.. (2024). rhIL-7-hyFc, a long-acting interleukin-7, improves efficacy of CAR-T cell therapy in solid tumors. Journal for ImmunoTherapy of Cancer. 12(7). e008989–e008989. 14 indexed citations
4.
Luo, Jingqin, Christopher L. Grote, Leslie Nehring, et al.. (2024). CTIM-24. PHASE II TRIAL OF RHIL-7-HYFC IN PATIENTS WITH HIGH-GRADE GLIOMA DEMONSTRATED ACCEPTABLE SAFETY PROFILE AND REDUCED LYMPHOPENIA. Neuro-Oncology. 26(Supplement_8). viii90–viii91.
5.
O’Neal, Julie, Matthew Cooper, Julie Ritchey, et al.. (2023). Anti-myeloma efficacy of CAR-iNKT is enhanced with a long-acting IL-7, rhIL-7-hyFc. Blood Advances. 7(20). 6009–6022. 20 indexed citations
6.
Xiang, Jingyu, Jessica M. Devenport, Karl Staser, et al.. (2023). An “Off-the-Shelf” CD2 Universal CAR-T Therapy Combined with a Long-Acting IL-7 for T-Cell Malignancies. Blood. 142(Supplement 1). 764–764. 3 indexed citations
7.
Naing, Aung, Hirva Mamdani, Minal Barve, et al.. (2023). 652 NT-I7 (efineptakin alfa), a long-acting IL-7, in combination with pembrolizumab improves T cell fitness in heavily pretreated subjects with gastrointestinal tumors. SHILAP Revista de lepidopterología. A743–A743. 1 indexed citations
8.
Wolfarth, Alexandra A., et al.. (2022). The Role of Interleukin-7 in the Formation of Tertiary Lymphoid Structures and Their Prognostic Value in Gastrointestinal Cancers. SHILAP Revista de lepidopterología. 5(4). 105–117. 10 indexed citations
9.
Wolfarth, Alexandra A., et al.. (2022). Advancements of Common Gamma-Chain Family Cytokines in Cancer Immunotherapy. Immune Network. 22(1). e5–e5. 13 indexed citations
10.
11.
Lee, Jung‐Yun, Su‐Young Lee, Joonheum Park, et al.. (2021). Immune Modulatory Activities of Arginyl-Fructose (AF) and AF-Enriched Natural Products in In-Vitro and In-Vivo Animal Models. Molecules. 26(8). 2251–2251. 9 indexed citations
12.
Jo, Yuna, et al.. (2020). Innovative CAR-T Cell Therapy for Solid Tumor; Current Duel between CAR-T Spear and Tumor Shield. Cancers. 12(8). 2087–2087. 22 indexed citations
13.
14.
Lee, Byung Ha, et al.. (2017). GROWTH-REGULATING FACTOR and GRF-INTERACTING FACTOR Specify Meristematic Cells of Gynoecia and Anthers. PLANT PHYSIOLOGY. 176(1). 717–729. 67 indexed citations
15.
Kim, Jong Hoon, Young Joon Choi, Byung Ha Lee, et al.. (2016). Programmed cell death ligand 1 alleviates psoriatic inflammation by suppressing IL-17A production from programmed cell death 1–high T cells. Journal of Allergy and Clinical Immunology. 137(5). 1466–1476.e3. 64 indexed citations
16.
Lee, Byung Ha, et al.. (2015). Genetic interaction between GROWTH-REGULATING FACTOR and CUP-SHAPED COTYLEDON in organ separation. Plant Signaling & Behavior. 10(2). e988071–e988071. 20 indexed citations
17.
Lee, Byung Ha, et al.. (2013). Autoantibodies against Muscarinic Type 3 Receptor in Sjögren's Syndrome Inhibit Aquaporin 5 Trafficking. PLoS ONE. 8(1). e53113–e53113. 61 indexed citations
18.
Cho, Kangwoo, et al.. (2009). Performance Evaluation of a Double Layer Biofilter System to Control Urban Road Runoff (I) - System Design -. Journal of The Korean Society of Water and Wastewater. 23(5). 599–608. 1 indexed citations
19.
Lee, Byung Ha, et al.. (2009). Effects of Y2O3 additions on the densification and thermal conductivity of spark plasma sintering AlN ceramics. Journal of Ceramic Processing Research. 10(1). 109–112. 3 indexed citations
20.
Lee, Byung Ha, Eun Yu Kim, Young Sam Seo, et al.. (2009). Overexpression of a Brassica rapa NGATHA Gene in Arabidopsis thaliana Negatively Affects Cell Proliferation During Lateral Organ and Root Growth. Plant and Cell Physiology. 50(12). 2162–2173. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Qingguo Zhao Breakdown of academic impact, for papers by Paola Moretto Breakdown of academic impact, for papers by Haitao Gu Breakdown of academic impact, for papers by Kana Hasegawa Breakdown of academic impact, for papers by Feifei Sun Breakdown of academic impact, for papers by Lan Yu Breakdown of academic impact, for papers by Gökhan Cildir Breakdown of academic impact, for papers by Souichi Oomizu Breakdown of academic impact, for papers by Madalena Costa Breakdown of academic impact, for papers by Marco Averbeck
Rankless by CCL
2026